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Nutritional requirements and  
parenteral nutrition in preterm infants
Introduction
Major developments in neonatal care such as the use of antenatal 
steroids, artificial ventilation including continuous positive 
airway pressure, and artificial surfactant therapy have resulted 
in improvement in the survival of preterm infants. Preterm birth, 
defined as being born before 37 completed weeks of gestation, is 
associated with major morbidities in both developed and developing 
countries. The major morbidities associated with preterm births 
include abnormal neurodevelopmental outcomes. Abnormal 
neurodevelopment in preterm infants has been associated with 
inadequate nutrition during the early postnatal period.1,2 Furthermore 
and in the short term, suboptimal nutrition is also associated 
with adverse outcomes which include increased susceptibility to 
infections, greater need for mechanical ventilation and development 
of chronic lung disease.3 Undernutrition during critical periods may 
result in reduced cell growth in different body systems including 
the cardiovascular system. This may result in chronic diseases, like 
cardiovascular disease, later on in life.4 Early adequate nutrition in 
this group of infants is therefore both important and imperative. 
Goals of nutrition in preterm infants
The goal of nutritional support in preterm infants is to achieve 
a postnatal growth rate similar to that of a normal fetus at the 
same postconceptual age. The American Academy of Pediatrics 
recommends that growth of postnatal preterm infants in both their 
anthropometric indices and body composition should be the same as 
the normal fetus of the same gestational age.5 In utero the growth 
of the fetus is achieved through accretion of the new tissue and 
replacement of water with protein and fat. The fetus grows at a 
minimum rate of 15 g/kg/day during mid-trimester and down to 
10 g/kg/day at term. The water content drops from about 90% at 24 
weeks of gestation to about 75% at term. The lipids and protein body 
content increases from about 2% and 8.8% at 24 weeks to about 
11% and 12% at term respectively.6 The weight gain of 15 g/kg/day 
during the postnatal growth in preterm infants is often not achieved 
because extrauterine compared to intrauterine life requires higher 
energy expenditure due to intensive care environment, illnesses, 
inadequate nutrition and other adverse conditions. 
Extrauterine growth failure which is defined as discharge weight 
< 10th percentile of expected intrauterine growth is common and has 
been documented to occur in 28% of preterm infants born between 
23 and 34 weeks of gestation.7 It has also been reported that the 
incidence of length and head circumference being < 10th percentile 
at discharge is 34% and 16% respectively.7 Dusick et al reported that 
97% and 40% of very low birth weight infants (birth weight <1 500 g) 
had growth failure at 36 weeks and 18-22 months post-conceptual 
age respectively.8 The reason for this is that preterm infants are often 
not fed enough protein and energy to meet requirements for growth 
similar to those of the normal fetus. This interpretation is supported by 
the fact that appropriate nutritional support ameliorates the protein 
and carbohydrate deficit and improves growth of preterm infants. 
The risk of growth failure increases with decreasing gestational age 
and birth weight. Therefore, very preterm and extreme low birth 
weight infants will need more intensive nutritional support. 
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Intrauterine growth is supported by continuous supply of nutrients from mother to the fetus throughout pregnancy therefore preterm birth 
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Nutritional requirements
In order to improve growth of preterm infants there should be no 
interruption of nutrient provision at the time of delivery. Nutrition 
must be provided to newborns soon after birth. The best way to 
provide nutrition to newborn infants is breast milk feeding. However, 
it may not always be possible to start feeds soon after birth and, even 
when such a practice is possible, oral feeds often do not provide 
adequate nutrition until full feeds are given, which might take seven 
to 10 days, if feeds are increased gradually at a rate of 20 ml/kg/day. 
To achieve neonatal growth rates similar to those of the normal fetus 
requires that early parenteral nutrition must be started soon after 
birth. In such cases it becomes important to know what nutrients 
to give and in what quantities. Major components of nutrients in 
preterm infants are appropriate amounts of essential nutrients via 
the parenteral route mainly glucose, lipids and amino acids (Table I). 
Table I: Nutrient, electrolyte, calcium and phosphorus requirements in 









Carbohydrates (glucose) 6-8 mg/kg/minute
Lipids 2.5–3.5 g/kg/day
Sodium
















Energy is required for different cellular and organ functions. It is 
stored as adenosine triphosphate (ATP) which provides cellular 
energy when hydrolyzed to adenosine diphosphate. Preterm infants 
have low energy reserves due to the fact that they are born before 
fat and glycogen reserves have accumulated. Energy requirements 
depend on the stage of development, and are higher at 24 weeks 
compared to 38 weeks gestational age. They are affected by resting 
energy expenditure and growth. Resting energy expenditure is 
affected by sleep state and activity levels, environmental factors 
such as thermoregulation and demands for tissue synthesis. 
Synthesis of new tissue (growth and repair) requires more energy 
and is affected by protein and energy intake. Major increases in 
lean and fat mass occur during the third trimester. Resting energy 
expenditure appears not to vary much with gestational age, having 
been estimated to be 50 kcal/kg/day, on average. Estimated average 
energy requirements for new tissue formation in preterm infants 
are 4.5-4.9 kcal/g.9,10 If the intrauterine average weight gain of 
15-17 g/kg/day is to be achieved, 67-83 kcal/kg/day will be needed 
in addition to the resting energy expenditure. In total, this will come 
to 120-130 kcal/ kg/ day of total energy intake. A number of National 
Committees have recommended a daily energy intake of 110- 
130 kcal/kg/ day in healthy premature infants to allow for growth 
rate similar to that of the intrauterine growth rate.11 
Carbohydrate requirements
In early gestation the brain is larger and accounts for nearly all of 
whole body glucose utilization rate. Glucose utilization rates are 
twice as high in early gestation as they are at term. Over the third 
trimester, other organs such as muscles, fat and bone develop and 
do not use glucose at the same rate as the brain resulting in less 
whole-body weight-specific glucose utilization. Therefore, glucose 
synthetic rates in preterm infants are much higher at 6-8 mg/kg/
minute compared to term infants who synthesise glucose at a rate of 
3-5 mg/kg/minute. Maintaining normal glucose concentrations that 
match those of the normally growing fetus (more than 50 mg/dl or 
2.8 mmol/l) is important for neurodevelopment.12 
Carbohydrates are the main energy source for the neonate receiving 
parenteral nutrition in the form of glucose. In order to ensure that 
preterm infants receive adequate amounts of glucose, glucose 
is initially delivered at the hepatic glucose production rate of 
6-8 mg/kg/minute. Glucose levels need to be monitored regularly 
with initiation of parenteral nutrition as preterm infants are at risk of 
developing hyperglycaemia. The aim is to maintain serum glucose 
concentrations between 2.5 and 8.0 mmol/l, to avoid hypoglycaemia 
and hyperglycaemia. If glucose serum levels are at these accepted 
levels, glucose infusion rate may be increased gradually by 
0.5-1 mg/kg/minute to a maximum glucose rate of 12–13 mg/kg/
minute to assist with delivery of energy and to support growth. 
Insulin may be used to achieve higher glucose delivery rates to 
provide more energy, but this is not a recommended practice as 
exogenous insulin may reduce protein synthesis and thereby affect 
growth.13 
Lipid requirements 
Lipid is a good source of energy because of its high energy-density 
(1 gram of fat provides 9 kcal or 37.8 Joules of energy, compared 
to 1 gram of carbohydrate and protein providing about 4 kcal or 
16.8 Joules each). Lipids also provide essential fatty acids which 
are required for brain development. Essential fatty acid deficiency 
can develop within the first 72 hours of life and can be avoided 
by giving at least 0.5-1 g/kg/day of intravenous lipids. Essential 
fatty acids are converted to long chain polyunsaturated fatty acid 
(PUFA). Docosahexaenoic acid is the main fatty acid in the brain. 
It accumulates in the brain mainly during the last trimester of 
pregnancy.14 Infants who do not get sufficient amounts of PUFA may 
have delayed visual development.15 Therefore PUFA appears to be 
important for brain and visual development.
Parenteral lipid emulsions also enable delivery of lipid soluble 
vitamins. Lipids may need to be restricted in patients with 
hyperbilirubinaemia approaching exchange levels because fatty 
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acids may displace bilirubin bound to albumin. Lipid infusion rate of 
3 g/kg/day is well tolerated without adverse effects and provides the 
required essential fatty acids and energy levels. 
Protein requirements 
Proteins are essential for normal growth and development. Growth 
of lean body mass is particularly dependent on protein intake in 
organs such as the brain. Preterm infants, when fed more protein 
and energy, have remarkable capacity for improved growth including 
parts of the brain that are particularly related to cognitive function. 
Preterm infants given early intravenous amino acid or enteral 
protein feeding show evidence of enhanced growth, including head 
circumference growth and brain size.16,17 Intravenous amino acids 
alone with or without glucose also stimulate insulin secretion which 
augments amino acid stimulation of protein synthesis and protein 
accretion.
Amino acids should be provided soon after birth in order to 
prevent protein breakdown and promote growth and remodeling 
of cells, tissues and organs at rates that mimic the growth and 
body composition of the healthy fetus growing in utero. In order 
to maintain growth similar to that seen in utero high amino acid 
infusion rates must be provided. Protein must be administered 
with energy since, in the absence of non-protein energy, protein 
is oxidized and is not unavailable for protein synthesis. Increasing 
non-protein energy intake improves nitrogen retention by enhancing 
amino acid utilization for protein synthesis.
The normal fetus at mid-gestation is estimated to require 4g/kg/day 
of protein.6 A number of studies have reported that failure to provide 
dietary protein of at least 1 g/kg/day will result in protein breakdown, 
presenting as negative nitrogen balance.18-22 An amount of 
25-40 kcal or 105-168 Joules of non-protein energy per gram of 
protein intake will optimize protein deposition.23 Therefore, a minimum 
of 1 g/kg/day of protein together with 30 kcal/kg/day of non-protein 
energy will prevent negative nitrogen balance. It is recommended that 
postnatal, intravenous amino acids must be administered to provide 
protein of 3.5–4.0 g/kg/day for infants < 30 weeks gestational 
age; 2.5-3.5 g/kg/day for those between 30 and 36 weeks and 
1.5-2.5 g/kg/ day for infants > 36 weeks’ gestational age.24-26
Electrolytes, minerals, and vitamins
During the first week of life electrolytes needs are relatively low 
because of the free water diuresis. The sodium requirements will 
vary from 0-3 mmol/kg/day in the first week of life. After the initial 
diuresis, amounts of 2-3 mmol/kg/day of sodium and potassium will 
be required to maintain serum levels in the normal range. During 
the growing phase, the sodium requirements may double up to 
4-6 mmol/kg/day. 
Calcium, magnesium and phosphorus are essential for tissue 
structure and function. During pregnancy the fetus obtains its 
calcium from the mother through active calcium transfer and this 
reaches a peak of 120-150 mg/kg of fetal weight per day during 
the last trimester. Therefore preterm infants born before the last 
trimester are at an increased risk of low bone mass and metabolic 
bone disease. It has been calculated that in the last trimester the 
daily accretion of calcium, phosphorus and magnesium are 120, 70 
and 3 mg/kg/day respectively.27 Providing calcium and phosphorus 
through parenteral nutrition is a challenge because of limited 
solubility. It has been recommended that parenteral nutrition should 
contain 12.5-15 mmol/l of elemental calcium and 13-15 mmol/l of 
phosphorus. At parenteral nutrition fluid intake of 150 ml/kg/day, this 
will provide 75–90 mg/kg/day of calcium and 60–70 mg/kg/day of 
phosphorus. A calcium to phosphorus ratio of 1.7:1 to 1.3:1 by weight 
has been recommended but it appears that 1.7:1 is the optimal ratio 
for bone mineralization.28 Higher early calcium (75 mg/kg/day) and 
phosphorus (44 mg/kg/day) intake delivered by parenteral nutrition 
appear to be tolerated and prevent bone strength decline in preterm 
infants in the first week of life.29
Vitamins are essential for growth and development. The infant 
requires both water- and fat-soluble vitamins. Water soluble 
vitamins need to be supplied regularly because they are not stored 
in significant amounts in the body. They should be administered as 
soon as parenteral nutrition is started. Preterm infants have low 
body stores of fat soluble vitamins at birth due to limited transfer 
of lipid-soluble substrate across the placenta. Therefore, provision 
of the latter should be started as soon as lipid containing parenteral 
nutrition is initiated. The actual vitamin requirements in preterm 
infants are not well determined. 
Complications
Complications due to parenteral nutrition may be categorised 
into four groups: central venous line related, mainly sepsis and 
thromboembolism; deficiency or excess of parenteral nutrition 
components namely, electrolytes, glucose, vitamins and minerals; 
liver abnormalities e.g. raised enzymes, cholestasis; and metabolic 
bone disease and growth impairment. 
Infection is probably the most serious complication associated 
with both peripheral and central intravenous catheters. The 
most commonly associated organisms are coagulase-negative 
Staphylococcus, Staphylococcus aureus and Candida species.30,31 
Peripheral lines may infiltrate within a short period and such tissue 
damage increases the risk of infection. Peripheral lines may become 
colonized at a rate of 30%, if they have been in place for more than 
three days.30 Central venous catheters can also be infected but have 
the advantage of lower risk of infiltration. 
Hyperglycaemia is a common problem in preterm infants on 
parenteral nutrition. The most common cause is high glucose 
infusion. Preterm infants who require parenteral nutrition are often 
ill with thermal instability, hypotensive in need of inotrope support 
and septic. In such infants, stress hormones such as catecholamines 
are released and inhibit insulin secretion and action, and promote 
glycogen breakdown leading to hyperglycaemia. Intravenous lipid 
infusion also contributes to hyperglycaemia by competitively limiting 
glucose oxidation and promoting gluconeogenesis.32 Treatment of 
hyperglycaemia might require that the glucose delivery is reduced 
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to 4 mg/kg/minute or less and limiting intravenous lipid infusion. 
Early use of amino acids in parenteral nutrition may reduce the risk 
of hyperglycaemia as amino acids may promote insulin secretion 
which will diminish hepatic glucose production and enhance glucose 
utilization. If hyperglycaemia, persists despite reducing glucose 
delivery rate, insulin infusion should be considered. 
There has been reluctance to provide early and high protein parenteral 
nutrition because of fear of potential amino acid toxicity, uremia and 
metabolic acidosis. These complications were seen more frequently 
during the earlier days of parenteral nutrition support when solutions 
that were being used were unbalanced with a relatively low essential 
amino acids content and a high in non-essential, potentially, toxic 
amino acid. Urea production is normally high when there are high 
rates of amino acid oxidation, which increase urea synthesis. This 
urea production can be avoided by minimizing amino acid oxidation 
and by providing adequate non-protein energy sources. A study 
by Ridout et al showed that there was no correlation between 
intravenous amino acid intake and urea oxidation in preterm infants, 
including the extremely low birth weight infants.33 A number of 
studies have not shown metabolic acidosis to be common in preterm 
infants fed relatively higher rates of amino acids.20,21,34 
Metabolic bone diseases associated with parenteral nutrition are 
related to abnormalities in calcium and phosphorus levels, and 
excess aluminium contamination.35 The pathogenesis of TPN 
associated liver diseases is not well understood. The initial pathology 
is usual cholestasis, followed by portal inflammation and bile duct 
proliferation. With prolonged use of TPN portal fibrosis and cirrhosis 
may develop. The cause of cholestasis is thought to be multifactorial 
and includes sepsis, lack of enteral nutrition, and quantity and 
composition of parenteral amino acids. 
Benefits of early aggressive nutrition in preterm 
infants
The change from a well-parenterally fed state in utero to the 
extrauterine life with different metabolic demands or physiological 
properties is a major challenge to the preterm born infant. If the 
preterm infant does not receive parenteral nutrition or full enteral 
feeding directly after birth, the infant will become catabolic with 
nitrogen losses. It is estimated that 1% of the endogenous body 
protein will be lost per day, if the preterm infant is provided with only 
glucose after birth.8,36 Therefore, there is an urgent need for optimal 
nutrition at the time of birth. 
In the past there has been reluctance to start parenteral nutrition soon 
after birth because of fear of hyperglycaemia, metabolic acidosis, 
and uraemia. However, early parenteral nutrition has been shown to 
reduce hyperglycaemia due to amino acids stimulating the release of 
insulin, thereby promoting glucose utilization. Metabolic acidosis and 
uraemia have not been found to be specific to parenteral nutrition 
(amino acids) but rather to be influenced by the general clinical 
condition of the infant.36-38 
It has been shown that increasing protein and energy intake within 
the first 24 hours after birth is associated with higher Mental 
Development Index scores.39 Starting parenteral nutrition on day one 
reduces the incidence of growth failure seen at 36 weeks postnatal 
age. Early lipid administration by day two of life is well tolerated.40 
Therefore, recommendations have been made that at least 1.5 g/kg/
day of protein should be started within the first 24 hours of life and 
then increased by 0.5-1 g/kg/day to 3.5-4.0 g/kg/day. Lipids should 
be provided between 24 and 48 hours of life at 0.5-1.0 g/kg/day 
and increased by 0.5-1.0 g/kg/day to 3.0-3.5 g/kg/day. A number 
of studies have reported on an aggressive approach of starting 
parenteral nutrition that provides protein ≥ 1.5 g/kg/day within the 
first 24 hours of life and lipids at 0.5-1.0 g/kg/day on day two.18,19,22 
These studies reported that early high protein and early lipid intake 
resulted in increased nitrogen balance and energy, without metabolic 
acidosis, or high levels of urea, cholesterol and triglycerides. 
Prepacked bags of parenteral nutrition should be available in the 
neonatal unit at all times to facilitate early commencement of 
nutrition soon after birth. Amino acids should be started within the 
first 24 hours of life at not less than 1.5 g/kg/ day. If the prepacked 
bags of TPN that are lipid free are not available then the TPN should 
be started on day 2 to provide protein at 1.0-1.5 g/kg/day. 
Monitoring infants on TPN 
Complications of parenteral nutrition can be related to lack or 
excess of electrolytes, minerals and nutrients in parenteral nutrition, 
therefore these should be monitored for. The suggested monitoring 
schedule and the parameters to be monitored for infants who are on 
parenteral nutrition are shown on Table II. 




Six to eight hourly while increasing 
glucose infusion rate
Once to twice a day once on stable 
glucose infusion
Serum electrolytes and urea Twice a week while increasing fluid 
rate, then weekly
Serum calcium, magnesium and 
phosphorus
Weekly
Liver function tests Weekly
Serum triglycerides Weekly
Urine glucose Same time as glucose or each urine
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